首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到19条相似文献,搜索用时 187 毫秒
1.
背景神经肽Y(NPY)是中枢神经及末梢神经重要的调节剂,作用广泛,包括调节心脏及血管正常的生理活动,并参与许多心血管疾病的发生发展.研究表明,急性的NPY 刺激可促进心肌细胞钙活动,对心肌产生正性肌力作用.而持续NPY刺激对心肌钙活动的影响及其机制,目前还未见报道.目的 观察NPY刺激对大鼠心肌细胞胞浆钙和肌浆网(SR)内钙分布的影响,以及Ca2 /CaM依赖的蛋白激酶Ⅱ(CaMK Ⅱ)在其中的作用.方法 用100 nmol/L NPY刺激Sprague-Dawley乳鼠心肌细胞24 h,CaMKⅡ特异性抑制剂KN-93干预.应用荧光染料Fluo-4 AM负载胞浆钙;Fluo-5N AM负载肌浆网内游离钙离子,所有钙影像均由激光共聚焦显微镜记录.应用Western-blot法和免疫荧光法检测Ca2 -ATP酶(SERCA2a)和ryanodine受体(RyR2)两种蛋白的分布及蛋白量的变化.结果 经100 nmol/L NPY刺激24 h后,与对照组相比,心肌细胞胞浆游离钙浓度明显升高(65.3±6.2 VS50.7±4.1,P<0.05),心肌细胞肌浆网内游离钙含量明显低于对照组(67.6±8.3 VS 85.5±6.0,P<0.05),而KN-93可抑制上述效应;NPY可增加SERCA2a和RyR2的蛋白表达(SERCA2a:2.4±0.7 VS对照组:1.4±0.3;RyRz:2.3±0.4 vs对照组:1.2士0.4),KN-93可抑制上述作用.结论 CaMK Ⅱ通过影响SERCA2a和RyR2,调控SR的钙转运,进而介导NPY刺激下的细胞内钙重分布效应.  相似文献   

2.
目的 研究Ca2+在肿瘤坏死因子α(TNF-α)诱导心肌细胞肥大中的作用.方法 Lowry法测心肌细胞蛋白含量;计算机图像分析系统测心肌细胞体积;3H-亮氨酸掺入法测心肌细胞蛋白合成;Till阳离子测定系统观察胞内[Ca2+]i瞬变.结果 IP3R阻断剂2-APB(30 μmol/L)或RyR阻断剂ryanodine (50 μmol/L)能降低由TNF-α(100μg/L)诱导的心肌细胞蛋白合成、蛋白含量以及细胞体积增加,二者合用抑制作用更强.L型Ca2+通道阻断剂nifedipine(50 μmol)对上述反应无明显作用(P>0.05).IP3R阻断剂2-APB(30μmol/L)或RyR阻断剂ryanodine(50 μmol/L)能降低由TNF-α(100 μg/L)诱导的心肌细胞内钙离子瞬变幅度增高,二者合用作用抑制更强.L型Ca2+通道阻断剂nifedipine(50μmol/L)对其无明显作用(P>0.05).结论 TNF-α通过调节心肌细胞内钙离子浓度从而诱导心肌细胞肥大.而在此过程中TNF-α可能主要是通过作用IP3R和RyR促使胞内钙贮库Ca2+释放而引起胞内钙离子水平增高的,而非通过打开L型Ca2+通道.  相似文献   

3.
目的探讨营养性低钙与慢性氟中毒细胞内钙超载的相关性。方法采用饮水加入氟化钠进行大鼠染毒实验,配以低钙饮食,应用Fura-2/AM荧光指示剂标记单细胞,显微荧光标记测定慢性氟中毒大鼠肝、肾、脑细胞内游离钙([Ca2 ]i)的变化。结果氟可刺激细胞内[Ca2 ]i水平增高,正常饮食投氟组肝、肾、脑细胞内[Ca2 ]i水平分别为(124.11±11.35)、(127.20±14.40)、(136.75±15.91)nmol/L,与正常饮食对照组(86.37±27.55)、(95.65±8.75)、(99.20±12.89)nmol/L比较,差异有统计学意义(t=4.001、4.706、4.953,P< 0.05);低钙饮食 氟组肝、肾、脑细胞内[Ca2 ]i水平[(151.57±19.61)、(162.62±31.41)、(158.79±27.65) nmol/L]与低钙饮食对照组[(103.17±14.29)、(103.59±11.40)、(115.26±30.91)nmol/L]比较,差异有统计学意义(t=4.789,P<0.05;t=8.581、6.003,P<0.01);低钙饮食 氟组骨病变明显:细胞内[Ca2 ]i水平与血清离子钙(i[Ca])、总钙(t[Ca])呈负相关(r=-0.59)。结论慢性氟中毒可致机体组织细胞钙超载,低钙可加重氟中毒时的细胞内钙超载,提示细胞内钙超载可能参与氟骨症发病机制并起着重要作用。  相似文献   

4.
目的 :研究黄芪对去甲肾上腺素 (NE)诱导大鼠心肌细胞内游离钙 [Ca2 + ]i 含量升高的作用。方法 :应用AR CM MIC阳离子检测系统 ,采用Ca2 + 指示剂Fura 2 /AM检测培养新生大鼠单个心肌细胞内游离钙的浓度 ,并观察Am对NE诱导大鼠心肌细胞内 [Ca2 + ]i 升高的影响。结果 :当细胞外Ca2 + 浓度为 1 .3mmol/L时 ,大鼠心肌细胞 [Ca2 + ]i 为 ( 97.1 1 +8.2 1 )nmol/L ,给予 1 0 -5mol/L的NE ,可使大鼠心肌细胞 [Ca2 + ]i 增至 ( 2 91 .73± 1 5 .0 3 )nmol/L,而经黄芪处理的大鼠心肌细胞的 [Ca2 + ]i则由 ( 95 .98±8.1 4)nmol/L增至 ( 1 1 4.2 8± 9.2 9)nmol/L。结论 :NE能诱导大鼠心肌细胞内游离钙含量明显升高 ,黄芪对心肌细胞静息 [Ca2 + ]i无明显影响 ,但能抑制NE诱导大鼠心肌细胞 [Ca2 + ]i 升高  相似文献   

5.
目的研究培哚普利在心力衰竭(心衰)治疗中对心肌细胞的收缩特性、钙瞬变及其调控蛋白的影响。方法通过缩窄雄性Wistar大鼠的腹主动脉,制成压力负荷增高性心衰模型。随机分成培哚普利治疗组(培哚普利组,3mg·kg-1·d-1)、心衰对照组和假手术对照组(假手术组)。12周后分离左室心肌细胞,测定单个心肌细胞在电刺激时的缩短分数、钙瞬变以及钠-钙交换蛋白(NCX1)、内质网Ca2+-ATPase(SERCA2)、受磷蛋白等钙调控蛋白的转录与翻译水平。结果心肌细胞的缩短分数(FS)和[Ca2+]imax在心衰对照组均明显低于假手术组[FS(%):7.51±1.15与13.21±1.49,[Ca2+]imax(nmol/L):330.85±50.05与498.16±14.07;均为P<0.01]。给予培哚普利治疗后,培哚普利组的FS和[Ca2+]imax分别为(10.89±1.18)%和(488.72±22.27)nmol/L,明显高于心衰对照组(均为P<0.01)。在心衰对照组,NCX1和受磷蛋白的mRNA水平显著高于假手术组,而SERCA2的mRNA却明显低于假手术组。在培哚普利组,其NCX1和SERCA2的mRNA水平则介于心衰对照组和假手术组之间,差异有统计学意义(均为P<0.05)。在心衰对照组及培哚普利组,NCX1的蛋白表达量分别是假手术组的(1.141±0.047)倍(P<0.01)和(1.074±0.081)倍(P=0.018),SERCA2的表达量则是假手术组的(0.803±0.100)倍(P<0.01)和(0.893±0.084)倍(P=0.003)。结论培哚普利抗心衰治疗能够减轻心肌细胞的钙瞬变及其调控蛋白的异常变化,使心衰中单个心肌细胞的收缩特性得到保护。  相似文献   

6.
研究慢性心房颤动 (简称房颤 )患者Ca2 + 调节蛋白 肌浆网Ca2 + ATP酶及罗纳丹受体 (RyR)mRNA表达的改变 ,探讨房颤时心房肌细胞钙超载的原因及其在房颤发生和维持中的作用。选择 2 0例风湿性心脏病 (以二尖瓣狭窄为主 )接受瓣膜置换术者 ,于术中插管前取右心耳组织约 10 0mg ,采用逆转录 聚合酶链式反应技术 ,测定肌浆网Ca2 + ATP酶及RyR2 mRNA的变化。结果 :房颤者肌浆网Ca2 + ATP酶及RyR2 mRNA水平较窦性心律者明显下调 (分别为 0 .85 4± 0 .2 0 7vs 1.832± 0 .379,P <0 .0 0 1;1.4 12± 0 .319vs 2 .2 5 0± 0 .4 6 8,P <0 .0 5 ) ,且与临床血流动力学参数及性别、年龄无显著相关性。结论 :房颤患者肌浆网Ca2 + ATP酶及RyR2 mRNA表达水平下调 ,表明心房肌浆网钙离子调节蛋白可能参与房颤的发生或维持  相似文献   

7.
肌浆网/内质网(SR/ER)是细胞内重要的钙储库及调控系统,主要通过Ca2+释放通道雷尼丁受体(RyR)和1,4,5-三磷酸肌醇受体(IP3R),以及Ca2+摄取蛋白肌浆网Ca2+-ATP酶(SERCA)和基质交感分子1(STIM1)等调节钙信号,维持细胞内钙稳态。研究发现,SR/ER钙平衡对细胞正常生理功能的发挥和信息传递非常重要,SR/ER钙稳态失调与缺血性心脏病、心肌肥厚、高血压及心力衰竭等心血管疾病的发生发展密切相关。本文就SR/ER钙调控在心血管疾病中的研究进展作一概述,重点阐述SR/ER钙离子通道和相关调控蛋白对细胞内钙信号的调节机制,以期为临床心血管疾病的治疗提供重要策略和潜在靶点。  相似文献   

8.
过量氟对肾细胞内游离钙及钙泵的影响   总被引:1,自引:2,他引:1  
目的探讨过量氟对肾细胞内游离钙([Ca2 ]i)及钙泵(Ca2 -ATPase)的影响及[Ca2 ]i在肾损害发生机制中的作用。方法应用饮水投氟方式喂养Wistar大鼠20周和原代培养肾小管上皮细胞染氟,采用生物化学方法检测血清内离子钙和总钙水平及肾细胞Ca2 -ATPase活性变化;使用Ca2 指示剂Fura-2测定肾细胞[Ca2 ]i。结果肾细胞[Ca2 ]i水平在常食投氟组和偏食投氟组较相应对照组明显增多;暴露于低钙高氟环境中的大鼠血清总钙降低,离子钙降低达到显著程度,该组肾细胞的钙泵(Ca2 -ATPase)活性比富钙投氟组明显低;低氟(1.0-5.0mg/L)处理肾小管上皮细胞钙泵活力明显增高,但随着氟水平的提高(>7.5mg/L),Ca2 -ATPase活力明显下降。结论高氟直接抑制钙泵活性很可能造成肾细胞内[Ca2 ]i潴留,而[Ca2 ]i升高很可能是过量氟导致肾损害的一种重要机制。  相似文献   

9.
Fura-2/AM荧光法测定日本血吸虫培养细胞内游离钙离子浓度   总被引:6,自引:0,他引:6  
目的 研究用钙荧光探剂 (Fura- 2 / AM)检测静息状态下日本血吸虫培养细胞内的游离钙离子浓度 ([Ca2 + ]i) ,以及β-巯基乙醇对培养细胞 [Ca2 + ]i的影响。方法 将 18d虫龄的日本血吸虫童虫制成细胞悬液 ,贴壁法接种于 30 ml培养瓶中 ,培养液为 RPMI- 16 4 0含 2 0 %小牛血清及常量抗生素。在培养的 0 - 3d,制备日本血吸虫细胞悬液 ,采用 Fura- 2 / AM钙荧光探剂测定正常静息状态下及加入β-巯基乙醇后日本血吸虫培养细胞内的 [Ca2 + ]i。结果 正常静息状态下 ,培养 0 d的日本血吸虫培养细胞内的 [Ca2 + ]i为 188.2 nmol/ L ;培养 1- 3d的 [Ca2 + ]i两两比较差异无显著性(P>0 .0 5 ) ,它们的平均值为 (187.0± 10 .7) nm ol/ L ,与培养 0 d的 [Ca2 + ]i比较 ,差异也无显著性(P>0 .0 5 )。β-巯基乙醇可使日本血吸虫培养细胞内 [Ca2 + ]i明显升高 (P<0 .0 1) ,并随浓度的增加而升高。结论 培养 1- 3d,静息状态下日本血吸虫培养细胞内的 [Ca2 + ]i比较稳定 ,β-巯基乙醇能影响日本血吸虫培养细胞内的 [Ca2 + ]i  相似文献   

10.
目的观察脾气虚大鼠骨骼肌组织Ca2+/钙调蛋白(Ca M)信号通路中关键分子〔Ca2+〕i以及Ca M、钙调蛋白激酶(Ca MK)Ⅱ、pCa MKⅡ蛋白表达水平的变化。方法受试动物随机分为正常对照组,脾虚模型7、14、21 d组,每组12只。除正常对照组外,其余受试动物采用复合法(苦寒破气法、游泳力竭法及饥饱失常法)成功建立脾气虚证大鼠模型,在观测各组大鼠一般生存状态、胃肠转运功能和骨骼肌组织ATP酶活性的基础上,采用激光共聚焦技术检测骨骼肌组织细胞内〔Ca2+〕i浓度,蛋白免疫印迹技术检测骨骼肌组织Ca M、Ca MKⅡ和p-Ca MKⅡ的表达变化。结果与空白组比较,脾气虚大鼠随着造模时间的延长,胃残留率升高而小肠推进率下降(P0.01);骨骼肌组织Na+-K+-ATPase和Ca2+-Mg2+-ATPase活性均降低(P0.05,P0.01);骨骼肌组织〔Ca2+〕i浓度和Ca M、Ca MKⅡ、p-Ca MKⅡ蛋白表达量显著降低(P0.01);且脾虚模型7 d、14 d、21 d组之间比较,以脾虚21 d组变化更为显著。结论脾虚大鼠骨骼肌组织Ca2+/Ca M信号通路关键分子Ca M、Ca MKⅡ和p-Ca MKⅡ蛋白以低表达为主。  相似文献   

11.
To observe the dynamic expression of calcium-sensing receptor (CaSR) in myocardium of diabetic rats and explore its role in diabetic cardiomyopathy (DCM), 40 male Wistar rats were randomly divided into 4 groups including control, diabetic-4 weeks, diabetic-8 weeks and spermine treatment groups (240 μM of spermine in drinking water). The type 2 Diabetes mellitus (DM) models were established by intraperitoneal injection of streptozotocin (STZ, 30 mg/kg) after high-fat and high-sugar diet for one month. The echocardiographic parameters were measured, cardiac morphology was observed by electron microscope and HE staining. The intracellular calcium concentration ([Ca(2+)](i)) was detected by laser-scanning confocal microscope. Western blot analyzed the expression of CaSR, protein kinase C α(PKC-α) and calcium handling regulators, such as phospholamban (PLN), Ca(2+)-ATPase (SERCA), and ryanodine receptor (RyR). Compared with control group, [Ca(2+)](i) and the expression of CaSR, RyR and SERCA/PLN were decreased, while PKC-α and PLN were significantly increased in a time-dependent manner in diabetic groups. Meanwhile diabetic rats displayed abnormal cardiac structure and systolic and diastolic dysfunction, and spermine (CaSR agonist) could prevent or slow its progression. These results indicate that the CaSR expression of myocardium is reduced in the progress of DCM, and its potential mechanism is related to the impaired intracellular calcium homeostasis.  相似文献   

12.
Chronic hypoxia (CH) leads to the deterioration of myocardial functions with impaired calcium handling in the sarcoplasmic reticulum (SR), which may be mediated by oxidative stress. We hypothesized that administration of antioxidant melatonin would protect against cardiac and ischemia-reperfusion (I/R) injury by ameliorating SR calcium handling. Adult Sprague-Dawley rats that had received a daily injection of melatonin or vehicle were exposed to 10% oxygen for 4 wk. The heart of each rat was then dissected and perfused using a Langendorff apparatus. The ratio of heart-to-body weight, ventricular hypertrophy and hematocrit were increased in the hypoxic rats compared with the normoxic controls. Malondialdehyde levels were also increased in the heart of hypoxic rats and were lowered by the treatment of melatonin. The hearts were subjected to left coronary artery ischemia (30 min) followed by 120-min reperfusion. Lactate dehydrogenase leakage before ischemia, during I/R and infarct size of the isolated perfused hearts were significantly elevated in the vehicle-treated hypoxic rats but not in the melatonin-treated rats. Spectroflurometric studies showed that resting calcium levels and I/R-induced calcium overload in the cardiomyocytes were more significantly altered in the hypoxic rats than the normoxic controls. Also, the hypoxic group had decreased levels of the SR calcium content and reduced amplitude and decay time of electrically induced calcium transients, indicating impaired contractility and SR calcium re-uptake. Moreover, there were reductions in protein expression of calcium handling proteins, markedly shown at the level of SR-Ca(2+) ATPase (SERCA) in the heart of hypoxic rats. Melatonin treatment significantly mitigated the calcium handling in the hypoxic rats by preserving SERCA expression. The results suggest that melatonin is cardioprotective against CH-induced myocardial injury by improving calcium handling in the SR of cardiomyocytes via an antioxidant mechanism.  相似文献   

13.
目的探讨血管紧张素Ⅱ受体拮抗剂氯沙坦干预慢性心力衰竭对兔心肌肌浆网钙泵(SERCA2)、钙释放通道(RyR2)、受磷蛋白(PLB)基因表达的影响及意义。方法通过结扎兔冠状动脉前降支复制心肌梗死(心梗)模型,以氯沙坦进行干预。于心梗后8周比较观察左室结构、血流动力学的变化及SERCA2、RyR2、PLB基因的表达。结果与对照组相比,心梗组左室舒张末压(LVEDP)显著升高(P〈0.01),左室压力上升和下降最大速度(+dr,/dtmax、-dp/dtmax)显著降低(P〈0.01);氯沙坦组LVEDP显著低于心梗组(P〈0.05),+dp/dtmax、-dp/dtmax显著高于心梗组(P〈0.05)。心梗组SERCA2、RyR2、PLBmRNA显著低于对照组(P〈0.01),而氯沙坦组的上述三项显著高于心梗组(P〈0.05)。结论氯沙坦长期干预心力衰竭,能够改善心脏舒缩功能,可能与其上调肌浆网的钙调控蛋白SERCA2、RyR2、PLB的基因表达有关。  相似文献   

14.
15.
In gastrocnemius muscle from newborn rats the mRNA for the fast sarcoplasmic reticulum (SR) Ca(2+)-ATPase isoform (SERCA1) comprised over 90% of total SR Ca(2+)-ATPase mRNA content and increased 5-fold between day 5 and 20 after birth, whereas in hypothyroid muscle the SERCA1 message level remained constant. Triiodothyronine (T3) treatment of 2-day-old euthyroid rats induced a precocious stimulation of SERCA1 mRNA levels, indicating that T3 is the determining factor in the stimulation of SERCA1 message levels and that this stimulation underlies the previously reported effect of the thyroid status on the neonatal development of SR Ca(2+)-ATPase activity. The low mRNA level for the slow SR Ca(2+)-ATPase isoform (SERCA2) was constant in both euthyroid and hypothyroid muscle development. Nevertheless, T3 treatment of hypothyroid neonates induced a transient stimulation of SERCA2 message levels, indicating that SERCA2 is responsive to higher levels of T3.  相似文献   

16.
OBJECTIVE: To determine whether heart failure in rats is associated with altered expression of the skeletal muscle sarcoplasmic reticulum Ca2+-ATPase (SERCA). METHODS: SERCA protein and mRNA were examined in the soleus muscles of eight female rats with heart failure induced by coronary artery ligation, six weeks after the procedure (mean (SEM) left ventricular end diastolic pressure 20.4 (2.2) mm Hg) and in six sham operated controls by western and northern analyses, respectively. RESULTS: SERCA-2a isoform protein was reduced by 16% (112 000 (4000) v 134 000 (2000) arbitrary units, p < 0.001), and SERCA-2a messenger RNA was reduced by 59% (0.24 (0. 06) v 0.58 (0.02) arbitrary units, p < 0.001). Although rats with heart failure had smaller muscles (0.54 mg/g v 0.66 mg/g body weight), no difference in locomotor activity was observed. CONCLUSIONS: These results may explain the previously documented abnormalities in calcium handling in skeletal muscle from animals with the same model of congestive heart failure, and could be responsible for the accelerated muscle fatigue characteristic of patients with heart failure.  相似文献   

17.
Efficient and rhythmic cardiac contractions depend critically on the adequate and synchronized release of Ca2+ from the sarcoplasmic reticulum (SR) via ryanodine receptor Ca2+ release channels (RyR2) and its reuptake via sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2a). It is well established that this orchestrated process becomes compromised in diabetes. What remain incompletely defined are the molecular mechanisms responsible for the dysregulation of RyR2 and SERCA2a in diabetes. Earlier, we found elevated levels of carbonyl adducts on RyR2 and SERCA2a isolated from hearts of type 1 diabetic rats and showed the presence of these posttranslational modifications compromised their functions. We also showed that these mono- and di-carbonyl reactive carbonyl species (RCS) do not indiscriminately react with all basic amino acid residues on RyR2 and SERCA2a; some residues are more susceptible to carbonylation (modification by RCS) than others. A key unresolved question in the field is which of the many RCS that are upregulated in the heart in diabetes chemically react with RyR2 and SERCA2a? This brief review introduces readers to the field of RCS and their roles in perturbing SR Ca2+ cycling in diabetes. It also provides new experimental evidence that not all RCS that are upregulated in the heart in diabetes chemically react with RyR2 and SERCA2a, methylglyoxal and glyoxal preferentially do.  相似文献   

18.
心力衰竭家兔心肌细胞钙调控蛋白表达的异常   总被引:3,自引:1,他引:2  
目的探讨心力衰竭(心衰)心肌细胞钙调控蛋白表达异常的临床意义。方法 16只家兔随机分为两组,假手术组和心衰组各8只。通过超容量负荷联合压力负荷建立家兔心衰模型,利用心导管术和心脏多普勒观察手术前后家兔血流动力学及心脏结构和功能的变化。采用蛋白免疫印迹(Western blot)法测定心肌组织 L 型钙通道(LTCC)、肌浆网钙释放通道(RyR2)、肌浆网钙泵(SERCA2a)以及钠钙交换体(NCX)表达水平。结果家兔心衰组与假手术组相比,左室/体重比值、心率、左室舒张末压明显增加(P<0.01);左室短轴缩短率[(21.3±4.00)%与(36.5±1.36)%]和左室射血分数(0.45±0.07与0.70±0.02)降低(P<0.01);心肌组织 LTCC、RyR2表达下降(R_(LTCC/actin):0.287±0.029与0.624±0.009,R_(RyR2/actin):0.106±0.001与0.203±0.011,P<0.01);SERCA2a、NCX 表达增加(R_(NCX/actin:0.497±0.015与0.221±0.014,R_(SERCA2a/actin:0.611±0.036与0.433±0.008,P<0.01)。结论 LTCC 和 RyR2表达下调是心衰心肌收缩力降低的因素之一,而心衰早期 SERCA2a、NCX 表达增加可能有利于心肌舒缩功能的保持。  相似文献   

19.
目的 探讨大鼠心肌细胞核对外源性钙调素入核转运的调节机制及其在大鼠心肌肥厚时的变化。方法 制备腹主动脉缩窄心肌肥厚大鼠模型、差速离心提纯心肌细胞核、酶学方法测定钙 ATP酶活性、荧光分光光度计测定荧光标记钙调素向细胞核转入量。结果 离体纯化的大鼠心肌细胞核在ATP存在下 ,外源性钙调素经核孔向核内转运量具有显著钙离子浓度依赖性 ,随核外钙离子浓度的增加而递增 (P <0 0 5 )。在钙离子浓度为 10 -3 mol/L时 ,钙 ATP酶抑制剂thapsigargin (5μmol/L)、兰尼碱受体拮抗剂钌红 (rutheniumred ,5 0 μmol/L)和IP3 受体拮抗剂肝素 (10 μg/ml)使外源性钙调素的细胞核孔转运分别降低 90 %、2 0 %和 89% (P <0 0 5 )。腹主动脉缩窄术后 4周大鼠心肌显著肥厚 ,伴有明显的血流动力学异常 ,与对照组相比 ,腹主动脉缩窄心肌肥厚大鼠外源钙调素入核转运明显减少 (P <0 0 5 ) ,心肌细胞核钙 ATP酶活性显著下降 (P <0 0 0 1)。结论 外源性钙调素入核转运可能受核外钙离子浓度和核钙摄取、释放系统所调节 ,心肌肥厚时 ,钙调素入核转运减少、心肌细胞核钙 ATP酶活性下降 ,可能在相对稳定核功能紊乱的调节中起负性反馈作用。  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号